458 related articles for article (PubMed ID: 29424901)
1. LncRNA TUC338 promotes invasion of lung cancer by activating MAPK pathway.
Zhang YX; Yuan J; Gao ZM; Zhang ZG
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):443-449. PubMed ID: 29424901
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ASAP1-IT1 promotes cell proliferation, invasion and metastasis through the PTEN/AKT signaling axis in non-small cell lung cancer.
Zhang L; Shi SB; Zhu Y; Qian TT; Wang HL
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):142-149. PubMed ID: 29364481
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
Zhang L; Zhou XF; Pan GF; Zhao JP
Biomed Pharmacother; 2014 May; 68(4):401-7. PubMed ID: 24721325
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA Lnc01614 promotes the occurrence and development of gastric cancer by activating EMT pathway.
Dong Y; Wang ZG; Chi TS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1307-1314. PubMed ID: 29565488
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
[TBL] [Abstract][Full Text] [Related]
6. LncRNA TUC338 is overexpressed in prostate carcinoma and downregulates miR-466.
Li G; Zhang Y; Mao J; Hu P; Chen Q; Ding W; Pu R
Gene; 2019 Jul; 707():224-230. PubMed ID: 31085276
[TBL] [Abstract][Full Text] [Related]
7. LncRNA AOC4P affects biological behavior of gastric cancer cells through MAPK signaling pathway.
Qu CX; Shi XC; Bi H; Zhai LQ; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8852-8860. PubMed ID: 31696472
[TBL] [Abstract][Full Text] [Related]
8. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
9. A Novel Long Noncoding RNA (lncRNA), LL22NC03-N64E9.1, Promotes the Proliferation of Lung Cancer Cells and is a Potential Prognostic Molecular Biomarker for Lung Cancer.
Jing H; Qu X; Liu L; Xia H
Med Sci Monit; 2018 Jun; 24():4317-4323. PubMed ID: 29935018
[TBL] [Abstract][Full Text] [Related]
10. Study on the function and mechanism of long non-coding RNA DMTF1v4 in the occurrence of colon cancer.
Zhuang ST; Cai YJ; Gao HC; Qiu JF; Zeng L; Zheng WJ
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3779-3788. PubMed ID: 29949153
[TBL] [Abstract][Full Text] [Related]
11. lncRNA CCHE1 increased proliferation, metastasis and invasion of non-small lung cancer cells and predicted poor survival in non-small lung cancer patients.
Liao Y; Cheng S; Xiang J; Luo C
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1686-1692. PubMed ID: 29630113
[TBL] [Abstract][Full Text] [Related]
12. The LncRNA EPEL Promotes Lung Cancer Cell Proliferation Through E2F Target Activation.
Park SM; Choi EY; Bae DH; Sohn HA; Kim SY; Kim YJ
Cell Physiol Biochem; 2018; 45(3):1270-1283. PubMed ID: 29448242
[TBL] [Abstract][Full Text] [Related]
13. lncRNA AFAP1-AS1 Promotes Migration and Invasion of Non-Small Cell Lung Cancer via Up-Regulating IRF7 and the RIG-I-Like Receptor Signaling Pathway.
Tang XD; Zhang DD; Jia L; Ji W; Zhao YS
Cell Physiol Biochem; 2018; 50(1):179-195. PubMed ID: 30278439
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
15. LncRNA CASC11 promotes the development of esophageal carcinoma by regulating KLF6.
Chen SG; Wang CH; He RQ; Xu RY; Ji CB
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8878-8887. PubMed ID: 31696474
[TBL] [Abstract][Full Text] [Related]
16. LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290.
Lai XJ; Cheng HF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):322-328. PubMed ID: 29424889
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling.
Tang Y; Xiao G; Chen Y; Deng Y
Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897
[TBL] [Abstract][Full Text] [Related]
18. Upregulated lncRNA SNHG1 contributes to progression of non-small cell lung cancer through inhibition of miR-101-3p and activation of Wnt/β-catenin signaling pathway.
Cui Y; Zhang F; Zhu C; Geng L; Tian T; Liu H
Oncotarget; 2017 Mar; 8(11):17785-17794. PubMed ID: 28147312
[TBL] [Abstract][Full Text] [Related]
19. lncRNA TUC338 is a potential diagnostic biomarker for bladder cancer.
Li G; Zhang Y; Mao J; Hu P; Chen Q; Ding W; Pu R
J Cell Biochem; 2019 Oct; 120(10):18014-18019. PubMed ID: 31162712
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.
Yu Y; Shen HM; Fang DM; Meng QJ; Xin YH
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4812-4819. PubMed ID: 30070314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
